Apple And J&J Collaborate On Large Atrial Fibrillation Study
Executive Summary
The Heartline Study is evaluating how the Apple Watch can identify and predict atrial fibrillation while improving cardiovascular outcomes and patients’ adherence to anticoagulant drugs.
You may also be interested in...
Apple Series 6 Watch Pumps Mobile Access To Blood Oxygen Saturation Measurement
The company is sponsoring research on how the blood oxygen sensor feature on its Apple Watch 6 could be applied to specific health problems.
Apple Adds Blood Oxygen Sensor To Apple Watch
The company is sponsoring research on how the blood oxygen sensor feature on its Apple Watch 6 could be applied to specific health problems.
FDA Explains Why It Approved Apple Watch's De Novo Despite Missing Primary Endpoint
De novo summary documents published by the US FDA sheds more light on the agency’s work approving two de novos for Apple Watches last year. At the time, the approvals sparked concern from industry stakeholders on whether the company received preferential treatment. Former FDA Commissioner Scott Gottlieb pushed back against the notion in a lengthy blog post late last year.